Table 3. Patient characteristics (phase II portion).
No. of patients | |
---|---|
No. of patients evaluated/eligible | 42/42 |
Median age, year (range) | 67 (29–75) |
Sex: male/female | 36/6 |
ECOG PS: 0/1 | 18/24 |
Weight loss | |
5% or more | 5 |
Less than 5% | 37 |
Histology | |
Adenocarcinoma | 12 |
Squamous cell carcinoma | 26 |
Unclassified | 4 |
Stage of disease: IIIA/ IIIB | 8/34 |
TNM classification | |
T2N2M0 | 5 |
T3N2M0 | 3 |
T1N3M0 | 2 |
T2N3M0 | 5 |
T3N3M0 | 4 |
T4N0M0 | 3 |
T4N1M0 | 3 |
T4N2M0 | 15 |
T4N3M0 | 2 |
ECOG=Eastern Corporative Oncology Group; PS=performance status.